Advanced Clinical Trials and Clinical Research

Diversity in Enrollment

Diverse participant enrollment is essential for generating generalizable, equitable clinical trial results. This session explores barriers to diversity—including socioeconomic, geographic, and cultural factors—and strategies to overcome them. Attendees will examine FDA and NIH guidance on inclusive enrollment practices and how to design protocols that accommodate underrepresented populations. Topics include community engagement, culturally tailored outreach, multilingual materials, and use of decentralized technology to reach rural or remote patients. Case studies will showcase successful diversity initiatives in oncology, cardiology, and vaccine trials. The session also discusses tracking demographic metrics, setting enrollment targets, and reporting outcomes to regulators and the public. Attendees will leave with actionable tools to implement inclusive recruitment plans that reflect real-world patient populations and promote health equity in research.